Collectively, these data indicate that, while mTOR is a pivotal regulator of tumor metabolism, invasion, and angiogenesis in ARMS, inhibition of mTOR alone is insufficient due to compensatory activation of parallel signaling pathways. This evidence concerns the gene MTOR and alveolar rhabdomyosarcoma.